Influenza A virus-IN-7
Modify Date: 2024-01-14 20:49:12
Influenza A virus-IN-7 structure
|
Common Name | Influenza A virus-IN-7 | ||
|---|---|---|---|---|
| CAS Number | 2464415-40-3 | Molecular Weight | 459.54 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H25N5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Influenza A virus-IN-7Influenza A virus-IN-7 (compound 16r) is a potent and orally active influenza A virus inhibitor with an IC50 of 3.43 µM and CC50 of >100 µM. Influenza A virus-IN-7 shows anti-IAV activity with low cytotoxicity. Influenza A virus-IN-7 inhibits the transcription and replication of viral RNA[1]. |
| Name | Influenza A virus-IN-7 |
|---|
| Description | Influenza A virus-IN-7 (compound 16r) is a potent and orally active influenza A virus inhibitor with an IC50 of 3.43 µM and CC50 of >100 µM. Influenza A virus-IN-7 shows anti-IAV activity with low cytotoxicity. Influenza A virus-IN-7 inhibits the transcription and replication of viral RNA[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 3.43 µM (influenza virus); CC50: >100 µM (influenza virus)[1] |
| In Vivo | Influenza A virus-IN-7 (compound 16r) (1.25 mg/kg for i.v.; 25 mg/kg for p.o.) shows good PK profiles with oral bioavailability of 22.5%[1]. Animal Model: Male SD rats[1] Dosage: 1.25, 25 mg/kg Administration: I.v. or p.o Result: Showed good PK profiles with oral bioavailability of 22.5%. |
| References |
| Molecular Formula | C29H25N5O |
|---|---|
| Molecular Weight | 459.54 |